Not Tagged
NeoGenomics Pharma
['melanoma', 'marker ']
the #esmo congress 2022 is happening through 9/13. the neogenomics pharma services division is presenting a poster titled, "pak4 as a potential marker for poor response to immunotherapy in melanoma patients." 